Loading...
XSHE
000661
Market cap5.61bUSD
Jul 14, Last price  
100.67CNY
1D
0.59%
1Q
4.06%
Jan 2017
-8.81%
Name

Changchun High & New Tech Industry Inc

Chart & Performance

D1W1MN
P/E
8.76
P/S
2.73
EPS
11.49
Div Yield, %
4.41%
Shrs. gr., 5y
3.80%
Rev. gr., 5y
22.07%
Revenues
14.57b
+15.35%
366,492,643486,854,804580,454,579662,056,599804,155,5501,023,586,7911,165,962,4101,294,589,2941,761,187,2182,048,692,2812,262,304,4482,402,089,6412,897,439,8034,102,261,5785,374,994,7087,373,701,2668,576,600,70810,746,717,26212,627,188,96614,566,039,611
Net income
4.53b
+9.47%
7,314,81605,267,4186,502,65420,094,87573,154,66486,461,380109,548,646299,797,507283,898,219318,171,323384,479,499484,852,471661,948,7691,006,495,3591,775,009,1973,046,586,1453,757,472,9534,140,523,8034,532,483,532
CFO
5.11b
+80.85%
089,905,032118,249,773211,528,771163,798,123390,330,399348,989,743169,181,491407,944,688498,580,431279,752,231770,595,142308,073,522381,387,328884,066,5721,934,670,6851,110,989,8543,330,619,2252,826,408,3335,111,442,136
Dividend
Apr 18, 20244.5 CNY/sh

Profile

Changchun High-Tech Industries (Group) Inc., together with its subsidiaries, manufactures and sells biopharmaceuticals and proprietary Chinese medicines in China. It also engages in real estate development, property management, and real estate leasing services. The company was formerly known as Changchun High & New Technology Industry (Group) Inc. Changchun High-Tech Industries (Group) Inc. was founded in 1993 and is based in Changchun, China.
IPO date
Dec 18, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
14,566,040
15.35%
12,627,189
17.50%
Cost of revenue
6,883,885
6,898,171
Unusual Expense (Income)
NOPBT
7,682,155
5,729,018
NOPBT Margin
52.74%
45.37%
Operating Taxes
734,452
709,241
Tax Rate
9.56%
12.38%
NOPAT
6,947,703
5,019,777
Net income
4,532,484
9.47%
4,140,524
10.19%
Dividends
(404,666)
(321,798)
Dividend yield
0.68%
0.47%
Proceeds from repurchase of equity
(218,563)
(87,773)
BB yield
0.37%
0.13%
Debt
Debt current
144,472
318,528
Long-term debt
712,476
1,174,349
Deferred revenue
120,543
135,124
Other long-term liabilities
120,716
307
Net debt
(7,912,092)
(5,323,870)
Cash flow
Cash from operating activities
5,111,442
2,826,408
CAPEX
(2,096,800)
Cash from investing activities
(2,289,724)
Cash from financing activities
(739,961)
FCF
4,912,092
2,369,058
Balance
Cash
7,593,774
5,578,513
Long term investments
1,175,266
1,238,234
Excess cash
8,040,738
6,185,388
Stockholders' equity
20,505,196
18,148,596
Invested Capital
17,926,258
16,005,826
ROIC
40.95%
35.55%
ROCE
29.45%
25.65%
EV
Common stock shares outstanding
409,809
407,532
Price
145.80
-12.41%
166.45
-38.67%
Market cap
59,750,099
-11.92%
67,833,679
-39.00%
EV
54,795,330
65,266,500
EBITDA
8,231,040
6,164,207
EV/EBITDA
6.66
10.59
Interest
38,130
43,745
Interest/NOPBT
0.50%
0.76%